Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03257761
Title Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Southern California

hepatocellular carcinoma

pancreatic cancer



Durvalumab + Guadecitabine

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC / Norris Comprehensive Cancer Center Recruiting Los Angeles California 90033 United States Details
Hoag Memorial Hospital Presbyterian Recruiting Newport Beach California 92663 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore Maryland 21287 United States Details
*Shaded cells indicate that there was no data available from for the field